TITLE

A Population of HLA-DR+ Immature Cells Accumulates in the Blood Dendritic Cell Compartment of Patients with Different Types of Cancer

AUTHOR(S)

Pinzon-Charry, Alberto; Ho, Christopher S. K.; Laherty, Richard; Maxwell, Tammy; Walker, David; Gardiner, Robert A.; O'Connor, Linda; Pyke, Christopher; Schmidt, Chris; Furnival, Colin; L�pez, Jose Alejandro

PUB. DATE

December 2005

SOURCE

Neoplasia;Dec2005, Vol. 7 Issue 12, p1112

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Dendritic cell (DC) defects are an important component of immunosuppression in cancer. Here, we assessed whether cancer could affect circulating DC populations and its correlation with tumor progression. The blood DC compartment was evaluated in 136 patients with breast cancer, prostate cancer, and malignant glioma. Phenotypic, quantitative, and functional analyses were performed at various stages of disease. Patients had significantly fewer circulating myeloid (CD11c+) and plasmacytoid (CD123+) DC, and a concurrent accumulation of CD11c- CD123- immature cells that expressed high levels of HLA-DR+ immature cells (DR+IC). Although DR+IC exhibited a limited expression of markers ascribed to mature hematopoietic lineages, expression of HLA-DR, CD40, and CD86 suggested a role as antigen-presenting cells. Nevertheless, DR+IC had reduced capacity to capture antigens and elicited poor proliferation and interferon-? secretion by T-lymphocytes. Importantly, increased numbers of DR+IC correlated with disease status. Patients with metastatic breast cancer showed a larger number of DR+IC in the circulation than patients with local/nodal disease. Similarly, in patients with fully resected glioma, the proportion of DR+IC in the blood increased when evaluation indicated tumor recurrence. Reduction of blood DC correlating with accumulation of a population of immature cells with poor immunologic function may be associated with increased immunodeficiency observed in cancer.

ACCESSION #

19877359

Tags: DENDRITIC cells;  IMMUNOSUPPRESSION;  CANCER;  TUMORS;  BREAST -- Cancer

 

Related Articles

• Dendritic cell density and activation status in human breast cancer -- CD I a, CMRF-44, CMRF-56 and CD-83 expression. Coventry, B.J.; Lee, P.-L.; Gibbs, D.; Hart, D.N.J. // British Journal of Cancer;2/12/2002, Vol. 86 Issue 4, p546 

  Low CD1a-positive putative dendritic celt numbers in human breast cancer has recently been described and may explain the apparent 'poor immunogenicity' previously reported in breast cancer. Little attention has been given to dendritic cell activation within the tumour microenvironment, which is...

• Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8 T cells. Mansfield, Aaron; Heikkila, Paivi; Smitten, Karl; Vakkila, Jukka; Leidenius, Marjut // Virchows Archiv;Oct2011, Vol. 459 Issue 4, p391 

  The regional immune systems of patients with breast cancer are immunosuppressed. Dendritic cells are professional antigen-presenting cells and present cancer-associated antigens to the adaptive immune system in sentinel lymph nodes. Dendritic cells may promote, or inhibit, an adaptive immune...

• Adoptive Transfer of Mammaglobin-A Epitope Specific CD8 T Cells Combined with a Single Low Dose of Total Body Irradiation Eradicates Breast Tumors. Lerret, Nadine M.; Rogozinska, Magdalena; Jaramillo, Andrés; Marzo, Amanda L. // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

  Adoptive T cell therapy has proven to be beneficial in a number of tumor systems by targeting the relevant tumor antigen. The tumor antigen targeted in our model is Mammaglobin-A, expressed by approximately 80% of human breast tumors. Here we evaluated the use of adoptively transferred...

• Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.  // Breast Cancer Research;2012, Vol. 14 Issue 1, p3135 

  The article focuses on a study that uses the mouse breast cancer model to investigate the immunogenicity of a human epidermal growth factor receptor (HER2) protein vaccine aimed at antigen uptake receptor DEC205 (DEC) and dendritic cells (DCs). Immunization of mice belonging to various genetic...

• In Vivo Imaging of Lymph Node Migration of MNP- and In-Labeled Dendritic Cells in a Transgenic Mouse Model of Breast Cancer (MMTV- Ras). Martelli, Cristina; Borelli, Manuela; Ottobrini, Luisa; Rainone, Veronica; Degrassi, Anna; Russo, Micaela; Gianelli, Umberto; Bosari, Silvano; Fiorini, Carlo; Trabattoni, Daria; Clerici, Mario; Lucignani, Giovanni // Molecular Imaging & Biology;Apr2012, Vol. 14 Issue 2, p183 

  Purpose: The authors present a protocol for the in vivo evaluation, using different imaging techniques, of lymph node (LN) homing of tumor-specific dendritic cells (DCs) in a murine breast cancer model. Procedures: Bone marrow DCs were labeled with paramagnetic nanoparticles (MNPs) or In-oxine....

• Biology Disease.  // Current Medical Literature: Breast Cancer;2003, Vol. 15 Issue 2, p40 

  Presents several medical studies on breast cancer. Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients; Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells;...

• CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer. Coventry, B J; Morton, J // British Journal of Cancer;8/4/2003, Vol. 89 Issue 3, p533 

  Infiltrating CD1a[SUP+] dendritic cells (DCs) have been associated with increased survival in a number of human cancers. This study investigated DC infiltration within breast cancers and the association with survival. Classical established prognostic factors, of tumour size, lymph node status,...

• Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production. Wang, Adele; Crome, Sarah; Jenkins, Kristina; Medin, Jeffrey; Bramson, Jonathan; Levings, Megan // Cancer Immunology, Immunotherapy;Mar2011, Vol. 60 Issue 3, p381 

  Dendritic cell (DC) vaccines offer a robust platform for the development of cancer vaccines, but their effectiveness is thought to be limited by T regulatory cells (Tregs). Recombinant adenoviruses (RAdV) have been used successfully to engineer tumor antigen expression in DCs, but the impact of...

• CITATIONS AND CLINICIANS' NOTES: BIOLOGY -- DISEASE.  // Current Medical Literature: Breast Cancer;2005, Vol. 17 Issue 1, p10 

  Provides information on several studies on the biology of breast cancer. "A Tumor-Associated Glycoprotein That Blocks MHC Class II-dependent Antigen Presentation by Dendritic Cells," by R. Gutzmer, W. Li, S. Sutterwala et al; "In Situ Analyses of Genome Instability in Breast Cancer," by K....

Read the Article